Robert Joy, MD
Clinical Cardiac Electrophysiology · Schenectady, NYNPI 1073527289
Payments from drug & device makers
Across 250 payments — averaging $39.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- Abbott$2K
- Boston Scientific$428
- Johnson & Johnson$397
- Novartis$305
- Abiomed$279
- plus $2K from 24 others
What the payments were for
- Travel & lodging$3,86639%
- Food & beverage$5,98061%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 42 | $4,760 |
| Abbott | 29 | $1,561 |
| Boston Scientific | 8 | $428 |
| Johnson & Johnson | 16 | $397 |
| Novartis | 25 | $305 |
| Abiomed | 12 | $279 |
| Regeneron Healthcare Solutions, Inc. | 11 | $233 |
| Amgen | 16 | $233 |
| Boehringer Ingelheim | 12 | $232 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 15 | $229 |
| Chiesi USA, Inc. | 14 | $217 |
| E.r. Squibb & Sons, L.L.C. | 9 | $136 |
| Biosense Webster, Inc. | 3 | $131 |
| Merck | 5 | $99 |
| AstraZeneca | 7 | $96 |
| Terumo Medical Corporation | 5 | $81 |
| Esperion Therapeutics, Inc. | 4 | $73 |
| Pfizer | 5 | $68 |
| Edwards Lifesciences | 1 | $57 |
| Cardiva Medical, Inc. | 1 | $43 |
| Irhythm Technologies, Inc. | 1 | $27 |
| Cardiovascular Systems Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $25 |
| Amarin Pharma, Inc. | 1 | $21 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Alnylam Pharmaceuticals Inc. | 1 | $16 |
| Teleflex LLC | 1 | $14 |
| Scpharmaceuticals Inc. | 1 | $14 |
| Silk Road Medical, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVERA MRI XT DR SURESCAN$1,414
- AVEIR$691
- Micra$311
- AURORA EV-ICD MRI SURESCAN$290
- Farapulse$147
- DUPIXENT$112
How this compares
$9,846 in reported general payments places this provider in the 25th percentile of 214 clinical cardiac electrophysiology providers in New York.
See all clinical cardiac electrophysiology providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 665 | $690,128 |
| XareltoRivaroxaban | 176 | $200,764 |
| EntrestoSacubitril/Valsartan | 68 | $92,714 |
| JardianceEmpagliflozin | 25 | $31,451 |
| FarxigaDapagliflozin Propanediol | 11 | $11,576 |
| Metoprolol Succinate | 533 | $8,045 |
| Atorvastatin Calcium | 409 | $5,404 |
| Ezetimibe | 60 | $2,688 |
| Rosuvastatin Calcium | 110 | $2,582 |
| Torsemide | 186 | $2,569 |
| Eplerenone | 19 | $2,005 |
| Potassium Chloride | 71 | $1,876 |
| Carvedilol | 156 | $1,608 |
| Losartan Potassium | 155 | $1,580 |
| Valsartan | 52 | $1,461 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $68 | $690,128665 claims |
| Johnson & JohnsonXarelto | $397 | $200,764176 claims |
| NovartisEntresto | $305 | $92,71468 claims |
| Boehringer IngelheimJardiance | $232 | $31,45125 claims |
| AstraZenecaFarxiga | $96 | $11,57611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 25th percentile of 214 clinical cardiac electrophysiology providers in New York.
Other clinical cardiac electrophysiology in Schenectady
- Vivek ReddyNew York$16.7M
- Srinivas DukkipatiNew York$4.2M
- Jacob KoruthNew York$4M
- Stavros MountantonakisManhasset$2.6M
- Jorge RomeroSyracuse$2.6M
- Larry ChinitzNew York$2.6M
- David HuangRochester$2.2M
- James IpNew York$1.2M
- Jonathan WillnerStaten Island$1.2M
- Christopher LiuNew York$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.